ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
MWN-AI** Summary
ZimVie Inc. (Nasdaq: ZIMV), a leader in the dental implant market, has announced a significant exclusive distribution agreement with Osstem Implant Co., Ltd. This strategic partnership aims to enhance ZimVie's footprint in the expansive Chinese market, which is projected to surpass 10 million dental implant units annually. Osstem, a prominent provider of dental implants in China since 2006, has established a strong distribution network across over 90 cities and conducts nearly 500 clinical training sessions each year, building trust with dental professionals and patients alike.
The agreement designates Osstem as the exclusive commercial partner for ZimVie's implant systems in China, allowing for a wider selection of premium products for customers. ZimVie’s CEO, Vafa Jamali, emphasized the strategic advantages of collaborating with a respected leader like Osstem, renowned for its outstanding service and product quality. This partnership will facilitate enhanced access for dental practitioners and their patients to advanced implant solutions.
Osstem’s Head of China operations, Michael Kim, expressed excitement about the partnership, highlighting how it will increase choices available to dental customers and improve patient outcomes. The collaboration is expected to leverage Osstem’s robust clinical education system and sales network to ensure a broader reach in the marketplace.
This distribution agreement underscores ZimVie’s commitment to innovation and global expansion, with an emphasis on delivering exceptional customer experiences. ZimVie aims to position itself as a preferred brand in dental implants worldwide, working continually to advance clinical science and technology, thereby improving the quality of life for patients through superior dental solutions.
MWN-AI** Analysis
ZimVie Inc.'s recent exclusive distribution agreement with Osstem Implant to expand its foothold in the rapidly growing Chinese dental implant market is a significant development worth noting for investors. This partnership not only enhances ZimVie's product accessibility but leverages Osstem's established reputation and extensive distribution network in China—an important market with over 10 million dental implants utilized annually.
Investors should consider several factors regarding this strategic move. Firstly, ZimVie is poised to benefit substantially from the educational efforts and established trust Osstem has garnered among dental professionals through nearly 500 clinical training sessions per year. This strong foundation provides ZimVie an edge in introducing its premium implant systems, which are designed for precision and durability. Such differentiation should attract more dentists and ultimately increase market penetration.
Moreover, as competition heats up in the dental implant segment, ZimVie’s ability to offer a broader product selection through this partnership signals a proactive approach to address varying customer needs, thus potentially increasing market share. The emphasis on clinical education and integrated solutions positions ZimVie favorably for long-term growth.
However, investors should remain aware of potential risks associated with this expansion. Market dynamics in China can be unpredictable, influenced by regulatory changes and varying consumer demand patterns. Furthermore, ZimVie’s forward-looking statements carry inherent risks; thus, close monitoring of their performance relative to these ambitious growth targets is advisable.
In conclusion, while the partnership with Osstem provides a promising outlook for ZimVie’s expansion in China, investors should weigh the opportunities against the risks, and consider holding or gradually increasing their position, contingent on tracking the company’s execution of its strategic objectives.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd. (“Osstem Implant”), a leading dental solutions provider specializing in high-quality implants and integrated dental technologies globally. The agreement expands ZimVie’s global presence to further penetrate the large, growing Chinese implant market—estimated at greater than 10 million units annually 1 —and enhance customer access to its innovative implant portfolio.
Osstem Implant is the market-leading provider of dental implants in China, with broad, established distribution channels. Since entering the Chinese market in 2006, Osstem has built a robust presence in over 90 cities and conducts nearly 500 clinical training sessions annually. This commitment to education, combined with high-quality products and extensive clinical validation, has earned Osstem strong trust among dental professionals and enabled the company to build a reliable and expansive distribution network. Under the agreement, Osstem Implant will have the exclusive commercial responsibility for ZimVie implant systems within the growing Chinese market, providing greater product selection for its vast customer base.
"Partnering with Osstem, a respected leader known for exceptional service and a strong portfolio of high-quality products, presents a superior opportunity for ZimVie to expand and grow in the Chinese market," said Vafa Jamali, Chairman of the Board and Chief Executive Officer of ZimVie.
“We are excited to partner with ZimVie, a company with outstanding clinical expertise and technological excellence,” said Michael Kim, Head of Osstem Implant’s China operations. “This collaboration allows us to offer more choices to our dental customers and patients. Through our strong clinical education system and extensive sales network, we will continue working to ensure that more dentists and patients benefit from high-quality implant treatments.”
The agreement reflects the strength and differentiation of ZimVie's premium implants, which are designed for precision, esthetics, and durability. It underscores the company’s commitment to innovation, global expansion, and its vision of creating great customer experiences to become the preferred dental implant brand for clinicians and patients worldwide.
1. National Conference on Oral Implantology; Qianzhan Industrial Research Institute
About ZimVie
ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at www.ZimVie.com . Follow @ZimVie on Twitter , Facebook , LinkedIn , or Instagram .
About Osstem Implant
Founded in South Korea in 1997 by a dentist, Osstem Implant has grown into the world’s largest dental implant manufacturer and the top dental company in the Asia-Pacific region. With 37 overseas subsidiaries in 33 countries and distribution in over 90 countries, Osstem delivers high-quality products and integrated dental solutions. The company is committed to contributing to better human health by enabling dentists to provide better treatment through bold investments in R&D, extensive clinical validation, and ongoing education programs.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.
Media Contact Information:
ZimVie
Grace Flowers • Grace.Flowers@ZimVie.com
(561) 319-6130
Investor Contact Information:
Gilmartin Group LLC
Webb Campbell • Webb@gilmartinir.com
FAQ**
How does the strategic distribution agreement with Osstem Implant enhance ZimVie Inc. ZIMV's competitive position in the rapidly growing Chinese dental implant market?
What specific innovative products from ZimVie Inc. ZIMV will Osstem Implant be distributing in China, and how do they compare to existing offerings in the market?
Given Osstem Implant's strong presence in China, what are the anticipated revenue and market share growth projections for ZimVie Inc. ZIMV as a result of this partnership?
How will ZimVie Inc. ZIMV leverage Osstem Implant's established distribution channels to ensure effective education and support for dental professionals in China?
**MWN-AI FAQ is based on asking OpenAI questions about ZimVie Inc. (NASDAQ: ZIMV).
NASDAQ: ZIMV
ZIMV Trading
0.34% G/L:
$18.995 Last:
201,196 Volume:
$18.99 Open:
